A number of challenges have emerged in the treatment of osteoporosis. This talk will take a case-based approach to discuss three such challenges: 1) denosumab withdrawal; 2) denosumab sequencing to an osteoanabolic agent; and 3) treatment considerations following an atypical femur fracture.